XML 61 R48.htm IDEA: XBRL DOCUMENT v3.3.1.900
ACQUISITIONS AND PRO FORMA RESULTS (Schedule of Assets Acquired and Liabilities Assumed) (Details) - USD ($)
$ in Thousands
12 Months Ended
Oct. 02, 2015
Dec. 05, 2014
Oct. 27, 2014
Jan. 24, 2013
Dec. 31, 2015
Dec. 31, 2014
Jan. 15, 2014
Business Acquisition [Line Items]              
Goodwill         $ 512,389 $ 363,479  
TEI Biosciences Inc and TEI Medical Inc.              
Business Acquisition [Line Items]              
Cash         1,241    
Accounts receivable, net         9,011    
Inventory         23,223    
Property, plant, and equipment         2,027    
Income tax receivable         5,135    
Other current assets         2,670    
Goodwill         147,878    
Total assets acquired         409,999    
Accrued expenses and other liabilities         9,732    
Deferred tax liabilities         87,908    
Other non-current liabilities         0    
Net assets acquired         312,359    
TEI Biosciences Inc and TEI Medical Inc. | Developed Technology              
Business Acquisition [Line Items]              
Intangible assets         167,400    
TEI Biosciences Inc and TEI Medical Inc. | Contractual Relationships              
Business Acquisition [Line Items]              
Intangible assets         51,345    
TEI Biosciences Inc and TEI Medical Inc. | Leasehold interest              
Business Acquisition [Line Items]              
Intangible assets         69    
Metasurg              
Business Acquisition [Line Items]              
Payments to Acquire Businesses, Gross   $ 26,500          
Inventory         4,800    
Property, plant, and equipment         1,246    
Goodwill         732    
Net assets acquired         27,558    
Metasurg | Technology              
Business Acquisition [Line Items]              
Intangible assets         20,590    
Medtronic MicroFrance              
Business Acquisition [Line Items]              
Payments to Acquire Businesses, Gross     $ 61,600        
Cash           2,195  
Inventory           3,155  
Property, plant, and equipment           3,675  
Other current assets           5,025  
Goodwill           16,607  
Total assets acquired           65,977  
Prepaid expenses           620  
Accounts payable and other liabilities           5,910  
Net assets acquired           60,067  
Medtronic MicroFrance | Technology              
Business Acquisition [Line Items]              
Intangible assets           4,580  
Medtronic MicroFrance | Trade names              
Business Acquisition [Line Items]              
Intangible assets           11,990  
Medtronic MicroFrance | Customer Relationships              
Business Acquisition [Line Items]              
Intangible assets           $ 18,130  
Confluent Surgical, Inc.              
Business Acquisition [Line Items]              
Property, plant, and equipment         438    
Goodwill         105,331    
Total assets acquired         349,981    
Other non-current liabilities         731    
Prepaid expenses         4,000    
Contingent supply liability         5,891    
Deferred tax liability         87,464    
Deferred tax assets - long term         12    
Net assets acquired         255,895   $ 255,900
Confluent Surgical, Inc. | Developed Technology              
Business Acquisition [Line Items]              
Intangible assets         239,800    
Confluent Surgical, Inc. | Other              
Business Acquisition [Line Items]              
Intangible assets         400    
Tarsus Medical, Inc.              
Business Acquisition [Line Items]              
Payments to Acquire Businesses, Gross       $ 4,700      
Cash       85      
Goodwill       116      
Total assets acquired       6,928      
Prepaid expenses       13      
Accounts payable and other liabilities       111      
Deferred tax liability       2,152      
Deferred tax assets - long term       1,334      
Net assets acquired       4,665      
Tarsus Medical, Inc. | Technology              
Business Acquisition [Line Items]              
Intangible assets       5,040      
Tekmed              
Business Acquisition [Line Items]              
Inventory         1,143    
Property, plant, and equipment         669    
Other current assets         11    
Goodwill         9,665    
Total assets acquired         16,469    
Accrued expenses and other liabilities         753    
Deferred tax liabilities         1,564    
Net assets acquired         14,152    
Tekmed | Supplier Contracts              
Business Acquisition [Line Items]              
Intangible assets         4,981    
Salto and Futura              
Business Acquisition [Line Items]              
Payments to Acquire Businesses, Gross $ 6,000            
Inventory         2,688    
Property, plant, and equipment         1,453    
Total assets acquired         7,811    
Deferred tax liabilities         700    
Net assets acquired         7,111    
Salto and Futura | Ankle product family              
Business Acquisition [Line Items]              
Intangible assets         $ 3,210    
Wtd. Avg. Life:         11 years    
Salto and Futura | Toe product family              
Business Acquisition [Line Items]              
Intangible assets         $ 460    
Wtd. Avg. Life:         10 years    
In-process research and development | Metasurg              
Business Acquisition [Line Items]              
In-process research and development         $ 190    
In-process research and development | Tarsus Medical, Inc.              
Business Acquisition [Line Items]              
In-process research and development       $ 340      
Maximum | TEI Biosciences Inc and TEI Medical Inc. | Developed Technology              
Business Acquisition [Line Items]              
Wtd. Avg. Life:         16 years    
Maximum | TEI Biosciences Inc and TEI Medical Inc. | Contractual Relationships              
Business Acquisition [Line Items]              
Wtd. Avg. Life:         14 years    
Maximum | Metasurg | Technology              
Business Acquisition [Line Items]              
Wtd. Avg. Life:         14 years    
Maximum | Medtronic MicroFrance | Technology              
Business Acquisition [Line Items]              
Wtd. Avg. Life:           16 years  
Maximum | Medtronic MicroFrance | Trade names              
Business Acquisition [Line Items]              
Wtd. Avg. Life:           20 years  
Maximum | Medtronic MicroFrance | Customer Relationships              
Business Acquisition [Line Items]              
Wtd. Avg. Life:           16 years  
Maximum | Confluent Surgical, Inc. | Technology              
Business Acquisition [Line Items]              
Wtd. Avg. Life:           20 years  
Maximum | Tarsus Medical, Inc. | Technology              
Business Acquisition [Line Items]              
Wtd. Avg. Life:       14 years      
Maximum | Tekmed | Supplier Contracts              
Business Acquisition [Line Items]              
Wtd. Avg. Life:         13 years    
Minimum | TEI Biosciences Inc and TEI Medical Inc. | Developed Technology              
Business Acquisition [Line Items]              
Wtd. Avg. Life:         14 years    
Minimum | TEI Biosciences Inc and TEI Medical Inc. | Contractual Relationships              
Business Acquisition [Line Items]              
Wtd. Avg. Life:         11 years    
Minimum | Metasurg | Technology              
Business Acquisition [Line Items]              
Wtd. Avg. Life:         8 years    
Minimum | Medtronic MicroFrance | Technology              
Business Acquisition [Line Items]              
Wtd. Avg. Life:           15 years  
Minimum | Medtronic MicroFrance | Customer Relationships              
Business Acquisition [Line Items]              
Wtd. Avg. Life:           12 years  
Minimum | Confluent Surgical, Inc. | Technology              
Business Acquisition [Line Items]              
Wtd. Avg. Life:           3 years  
Minimum | Tarsus Medical, Inc. | Technology              
Business Acquisition [Line Items]              
Wtd. Avg. Life:       10 years      
Minimum | Tekmed | Supplier Contracts              
Business Acquisition [Line Items]              
Wtd. Avg. Life:         2 years